Apr 15
|
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy for Long Term Growth?
|
Apr 15
|
Pfizer Halts Obesity Pill Development Amid Safety Concerns
|
Apr 15
|
VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study
|
Apr 15
|
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
|
Apr 15
|
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback
|
Apr 15
|
Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke
|
Apr 15
|
Eli Lilly and Company (LLY): One of the High Growth Forever Dividend Stocks to Invest In
|
Apr 15
|
Tariff wars to hit popular US-made drugs in China, regulator data shows
|
Apr 15
|
Trump Initiates Chips and Drug Probes Ahead of More Tariffs
|
Apr 14
|
Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data
|
Apr 14
|
Stocks to Watch Monday: Apple, Palantir, Intel, Pfizer
|
Apr 14
|
Eli Lilly's Mounjaro launch in India ignites wave of weight-loss enquiries
|
Apr 14
|
This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life.
|
Apr 14
|
Pharmaceutical Tariffs Coming Soon
|
Apr 14
|
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
|
Apr 14
|
Pfizer just had a big setback in its race for an Ozempic competitor
|
Apr 14
|
Jim Cramer on Eli Lilly and Company (LLY): “The Fastest Factory I’ve Ever Seen”
|
Apr 14
|
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury'
|
Apr 14
|
Pfizer discontinues GLP-1 pill trial, stock trades flat
|
Apr 14
|
Three Stocks That May Be Trading Below Their Estimated Value In April 2025
|